Rhinocerebral and systemic mucormycosis. Clinical experience with 36 cases

Journal of the Neurological Sciences

Volumn 143, Issue 1-2, 1996, Pages 19-30

  Rangel Guerra, Ricardo A ^a   Martínez, Héctor R ^a   Sáenz, Corando ^b   Bosques Padilla, Francisco ^a   Estrada Bellmann, Ingrid ^a  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

Amphotericin B; Fluconazole; Fungal infection; Mucormycosis; Rhinocerebral; Unstable diabetes; Zygomycetes

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; INSULIN; KETOCONAZOLE;

ADOLESCENT; ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; DEBRIDEMENT; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN TISSUE; MALE; MUCORMYCOSIS; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN DISEASES; DEBRIDEMENT; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUCORMYCOSIS; RETROSPECTIVE STUDIES; RHINITIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030296796     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(96)00148-7     Document Type: Review

References (31)

1. Abramson W, Wilson D, Arky R Rhinocerebral phycomycosis in association with diabetic ketoacidosis: report of 2 cases and a review of clinical and experimental experience with amphotericin B therapy. Ann Intern Med. 66:1967;735-742.
2. Bell WE Treatment of fungal infections of the central nervous system. Ann Neurol. 9:1981;417-422.
3. Boelaert JR, Fenves AZ, Coburn JW Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry. Am J Kidney Dis. 18:1991;660-667.
4. Brown JF, Gottlieb LS, McCormick RA Pulmonary and rhinocerebral mucormycosis. Successful outcome with amphotericin B and griseofulvin therapy. Arch Intern Med. 137:1977;936-938.
5. Cocanour CS, Miller-Crotchett P, Reed RL, Johnson PC, Fisher RP Mucormycosis in trauma patients. J Trauma. 32:1992;12-15.
6. Dhermy P. (1978) Phycomycosis (mucormycosis) in Vinken PJ, Bruyn GW (eds). Handbook of Clinical Neurology. New York, North Holland Publishing Co vol 35, chap 26, pp 541-555.
7. Dooley DP, Hollsten DA, Grimes SR, Moss J Indolent orbital apex syndrome caused by occult mucormycosis. J Clin Neuro-ophthalmol. 12:1992;245-249.
8. Downie JA, Francis IC, Arnold JJ, Bott LM, Koss S Sudden blindness and total ophthalmoplegia in mucormycosis. J Clin Neuroophthalmol. 13:1993;27-34.
9. Funada H, Misawa T, Nakao S, Saga T, Hattori K The air crescent sign of invasive pulmonary mucormycosis in acute leukemia. Cancer. 53:1984;2721-2723.
10. Gartenberg G, Botone EJ, Keush GTet al. Hospital-acquired mucormycosis (rhzopus rhizopodoformis) of the skin and subcutaneous tissue: Epidemiology mycology and treatment. NEJM. 229:1978;1115.
11. Hammond DE, Winkelmann RK Cutaneous phycomycosis: report of three cases with identification of rhizopus. Arch Dermatol. 115:1979;990-992.
12. Hammer GS, Bottone EJ, Hirschman SZ Mucormycosis in a transplant recipient. Am J Clin Pathol. 64:1975;389-398.
13. Hauch TW Pulmonary mucormycosis: Another cure. Chest. 62:1977;404-408.
14. Kaneko, Abe F, Ito M, Hotchi M, Okada Y Intestinal mucormycosis in a hemodyalisis patient treated with deferroxamine. Acta Pathol Jpn. 41:1991;561-566.
15. Lowe JT, Hudson WR Rhinocerebral phycomycosis in internal carotid artery thrombosis. Arch Otolaryngol. 101:1975;103.
16. Moderator, Lehrer RI Mucormycosis. Ann Intern Med. 93:1980;93-108.
17. Mc Bride RA, Corson JM, Dammin GJ Two cases of disseminated disease with cultural identification of Rhizopus: Review of literature. Am J Med. 28:1960;832-846.
18. Meyer RD, Rosen P, Armstrong D Phycomycosis complicating leukemia and lymphoma. Ann Intern Med. 77:1972;871-879.
19. Meyers BR, Wormser G, Hirischman SZet al. Rhinocerebral mucormycosis premortem diagnosis and therapy. Arch Intern Med. 139:1979;557-560.
20. Medoff G, Kobayashi GS Strategies in the treatment of fungal infections (medical progress). N Engl J Med. 302:1980;145-155.
21. Maartens G, Wood MJ The clinical presentation and diagnosis of invasive fungal infections. J Antimicrob Chemother. 28((suppl A)):1991;13-22.
22. Parfrey NA Improved diagnosis and prognosis of mucormycosis: A clinicopathologic study of 33 cases. Medicine. 65:1986;113-123.
23. Prevoo RL, Starink TM, deHaan P Primary cutaneous mucormycosis in a healthy young girl. Report of a case caused by Mucor hiemalis Wehmer. J Am Acad Dermatol. 24:1991;882-885.
24. Rangel-Guerra R, Martínez HR, Sáenz C Mucormycosis: Report of 11 Cases. Arch Neurol. 42:1985;578-581.
25. Sandler R, Tallman CB, Keamy KGet al. Successfully treated rhinocerebral phycomycosis in well-controlled diabetes. N Engl J Med. 285:1971;1180-1182.
26. Strasma BR, Zimmerman LE, Gass JDM Phycomycosis: A clinicopathologic study of 51 cases. Lab Invest. 11:1962;963-985.
27. Succar MB, Nichols RD, Burch KH Rhinocerebral mucormycosis. Arch Otolaryngol. 105:1979;212-214.
28. Sugar AM. (1992) Mucormycosis. Clin Infect Dis 14 (Suppl 1) S126-129.
29. Waldorf AR, Ruderman N, Diamond RD Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest. 74:1984;150-160.
30. Waldorf AR, Levitz SM, Diamond RD In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J Infect Dis. 150:1984;752-760.
31. Yohai RA, Bullock JD, Aziz AA, Markert RJ Survival Factors in Rhino-Orbital-Cerebral Mucormycosis. Surv Opthalmol. 39:1994;3-22.